GL1X · GenesisL1 explorer

Research workbench

Crystal structure of botulinum neurotoxin type B apo form

Analyse Crystal structure of botulinum neurotoxin type B apo form in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1S0G
Type
protein
Length
1,288 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Botulinum neurotoxin type B
EC
3.4.24.69
UniProt
P10844
Pockets
12 · best druggability 0.80

Structure

x-ray diffraction · 1 distinct chain · 32% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABotulinum neurotoxin type B (EC 3.4.24.69)protein128832% helix, 25% strandP10844

Pockets

12 pockets found on a 1 Å grid, 10 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18630.800.8271empty
23360.770.8851empty
33980.690.8146empty
43500.670.8136empty
54250.620.7637empty

Compared structures

  • 1S0G · Crystal structure of botulinum neurotoxin type B apo form · the same entry in another collection · chain A against A, TM-score 1.00
  • P10844 · AlphaFold monomer V2.0 prediction for botulinum neurotoxin type B (P10844) · a predicted model of the same protein · chain A against A, TM-score 0.67

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.